The Hospital Clínico San Carlos is a hospital located at the Ciudad Universitaria neighborhood in Madrid, Spain, part of hospital network of the Servicio Madrileño de Salud. It is one of the healthcare institutions associated to the Complutense University of Madrid for the purpose of clinical internship.

There are 861 beds in Hospital Clinico San Carlos.

During the past decade, Hospital Clinico San Carlos conducted 552 clinical trials. In the 10-year time frame, 552 clinical trials started and 177 clinical trials were completed, i.e. on average, 32.1% percent of trials that started reached the finish line to date. In the past 5 years, 263 clinical trials started and 119 clinical trials were completed. i.e. 45.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Clinico San Carlos" #1 sponsor was "PETHEMA Foundation" with 44 trials, followed by "Hospital San Carlos, Madrid" with 38 trials sponsored, "Pfizer" with 29 trials sponsored, "Spanish Breast Cancer Research Group" with 22 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 22 trials sponsored. Other sponsors include 716 different institutions and companies that sponsored additional 366 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Clinico San Carlos" #1 collaborator was "Merck Sharp & Dohme LLC" with 16 trials as a collaborator, "Hoffmann-La Roche" with 13 trials as a collaborator, "AstraZeneca" with 12 trials as a collaborator, "Instituto de Salud Carlos III" with 12 trials as a collaborator and "Bristol-Myers Squibb" with 11 trials as a collaborator. Other collaborators include 565 different institutions and companies that were collaborators in the rest 387 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Clinico San Carlos" are "Coronary Artery Disease" (40 trials), "Breast Cancer" (35 trials), "COVID-19" (17 trials), "Multiple Myeloma" (16 trials) and "HIV Infections" (15 trials). Many other conditions were trialed in "Hospital Clinico San Carlos" in a lesser frequency.

Most popular intervention types in "Hospital Clinico San Carlos" are "Drug" (568 trials), "Device" (117 trials), "Other" (87 trials), "Procedure" (61 trials) and "Biological" (51 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (106 trials), "Carboplatin" (18 trials), "Paclitaxel" (16 trials), "Pembrolizumab" (15 trials) and "Gemcitabine" (14 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Clinico San Carlos" are 764 trials for "All" genders, 90 trials for "Female" genders and 21 trials for "Male" genders.

Currently, there are 246 active trials in "Hospital Clinico San Carlos". 3 are not yet recruiting, 138 are recruiting, 101 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 461 completed trials in Hospital Clinico San Carlos, 2 suspended trials, and 85 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Clinico San Carlos, 49 "Phase 1" clinical trials were conducted, 213 "Phase 2" clinical trials and 290 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 85 trials, and there were also 95 trials that are defined as “Not Applicable".

Hospital Clinico San Carlos has several departments that took part in Clinical trials: "Hospital Universitario Clínico San Carlos; Servicio de Oncologia" - 45 trials, "Hospital Clinico San Carlos; Servicio de Nefrologia" - 4 trials, "Hospital Universitario Clínico San Carlos; Servicio de Hematología" - 4 trials, "Hospital Universitario Clínico San Carlos; Servicio de Neurología" - 4 trials, "Cardiovascular Institute - Hospital Clinico San Carlos" - 2 trials, "Hospital Clínico San Carlos - Servicio de Neumologia" - 2 trials